title: Protein kinase C-alpha in prostate cancer.
authors.affiliation: Divison of Oncology Product Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. mlahn@lilly.com
authors.forename: M
authors.initials: M
authors.lastname: Lahn
authors.forename: K
authors.initials: K
authors.lastname: Sundell
authors.forename: M
authors.initials: M
authors.lastname: Gleave
authors.forename: F
authors.initials: F
authors.lastname: Ladan
authors.forename: C
authors.initials: C
authors.lastname: Su
authors.forename: S
authors.initials: S
authors.lastname: Li
authors.forename: D
authors.initials: D
authors.lastname: Ma
authors.forename: B M
authors.initials: BM
authors.lastname: Paterson
authors.forename: T F
authors.initials: TF
authors.lastname: Bumol
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis; D015153:Blotting, Western; D054713:Bryostatins; D002455:Cell Division; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D018942:Macrolides; D008297:Male; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051571:Protein Kinase C-alpha; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D054713:Bryostatins; D007783:Lactones; D018942:Macrolides; D009363:Neoplasm Proteins; D012333:RNA, Messenger; C046785:bryostatin 1; C496628:PRKCA protein, human; D011493:Protein Kinase C; D051571:Protein Kinase C-alpha